Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19

Garth W Strohbehn1,2, Pankti D Reid3, Mark J Ratain1,2

  • 1Sections of Hematology/Oncology, Department of Medicine, The University of Chicago Medicine and Biological Sciences, Chicago, Illinois, USA.

Insights

The COVID-19 pandemic poses a significant public health risk. Effective treatment strategies and equitable resource distribution are urgently needed for overwhelmed hospitals during this global health crisis.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic presents a major global public health challenge.
  • Current mitigation strategies in Western nations have shown variable effectiveness.
  • Overwhelmed healthcare systems necessitate improved treatment and resource allocation strategies.

Purpose of the Study:

  • To highlight the urgent need for effective treatment strategies for COVID-19.
  • To address the critical requirement for equitable resource distribution in healthcare settings.
  • To inform strategies for managing overwhelmed hospitals during the pandemic.

Main Methods:

  • This study is a review of current public health and treatment strategies.
  • Analysis of the impact of COVID-19 on healthcare systems.
  • Examination of resource allocation challenges in pandemic scenarios.

Main Results:

  • Mitigation efforts have yielded inconsistent results across different regions.
  • There is a clear and present need for advanced therapeutic interventions.
  • Equitable distribution of medical resources remains a significant challenge.

Conclusions:

  • The COVID-19 pandemic demands immediate development and implementation of effective treatments.
  • Optimizing resource allocation is crucial for managing patient care and healthcare capacity.
  • Further research into novel treatment modalities and logistical strategies is essential.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
114
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
630
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
361
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
208